Evidence map›Paper›PMID 38108344›Full record

ArticleCancer biomarkers : section A of Disease markers2025

Liquid biopsy in clinical outcomes and detection of T790M mutation in metastatic non-small cell lung cancer after progression to EGFR-TKI.

David Heredia, Laura Bolaño-Guerra, Angel Valencia-Velarde, Edgar Varela Santoyo, Luis Lara-Mejía, Daniela Cárdenas-Fernández, Mario Orozco, Graciela Cruz-Rico, Oscar Arrieta

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer biomarkers : section A of Disease markers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

David HerediaThoracic Oncology Unit, Thoracic Oncology Department, Instituto Nacional de Cancerología, Mexico City, Mexico.
Laura Bolaño-GuerraMedical Oncology Department, Hospital Central Militar, Mexico City, México.
Angel Valencia-VelardeThoracic Oncology Unit, Thoracic Oncology Department, Instituto Nacional de Cancerología, Mexico City, Mexico.
Edgar Varela SantoyoMedical Oncology Department, Centro Oncológico Estatal, ISSSEMyN, Toluca, Mexico.
Luis Lara-MejíaThoracic Oncology Unit, Thoracic Oncology Department, Instituto Nacional de Cancerología, Mexico City, Mexico.
Daniela Cárdenas-FernándezThoracic Oncology Unit, Thoracic Oncology Department, Instituto Nacional de Cancerología, Mexico City, Mexico.
Mario OrozcoNeuroimmunology Laboratory, Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico.
Graciela Cruz-RicoThoracic Oncology Unit, Thoracic Oncology Department, Instituto Nacional de Cancerología, Mexico City, Mexico.
Oscar ArrietaThoracic Oncology Unit, Thoracic Oncology Department, Instituto Nacional de Cancerología, Mexico City, Mexico.ORCID 0000-0002-1164-3779
Instituto Nacional de Cancerología · MXHospital Central Militar · MXInstituto Nacional de Neurología y Neurocirugía · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUNDLiquid biopsy (LB) is used to detect epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) and has been demonstrated to have prognostic and predictive value.OBJECTIVETo associate the rates of

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsMutationProtein Kinase InhibitorsAdultAgedAged, 80 and overDisease ProgressionErbB ReceptorsFemaleHumansLiquid BiopsyMaleMiddle AgedNeoplasm MetastasisPrognosisEGFR protein, humanErbB ReceptorsProtein Kinase InhibitorsctDNAEGFRm NSCLCliquid biopsyosimertinibT790M mutation

Identifiers

PMID38108344
PMCPMC12288383
OpenAlexW4389613652

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.